Avoiding, Treating & Curing Cancer With the Immune System | Dr. Alex Marson

CAR-T therapy uses synthetic receptors

Scientists equip T-cells with lab-designed chimeric antigen receptors (CARs) that do not exist in nature, programming them to search for and destroy specific cancer cells when reinfused into patients like a blood transfusion.

Cellular reprogramming with DNA instructions

Modern medicine can now communicate with cells using the language of DNA through CRISPR and lipid nanoparticles, directing precise cell behaviors that were previously inconceivable.

Shift from chemicals to programmable cells

Treatment is evolving from searching for chemical pills to engineering living immune cells that can be instructed to recognize and eliminate tumors.

Innate versus adaptive immunity

The innate immune system uses dendritic cells and macrophages as a first alarm system for generic threats, while the adaptive system employs T-cells and B-cells for targeted, fine-tuned responses with memory.

Random T-cell receptor generation

Each T-cell creates unique surface receptors through random DNA recombination that is not inherited from parents, generating diversity capable of recognizing pathogens that may not even exist yet.

Thymus education prevents autoimmunity

T-cells mature in the thymus where they undergo positive selection to ensure they recognize foreign targets and negative selection to eliminate those that attack the body's own cells.

B-cell antibody coordination

B-cells undergo similar random recombination to produce antibodies that work in coordination with T-cells to neutralize invaders and provide lasting protection.

AI and massive-scale experimentation

Biology has shifted from observational science to interventional engineering, where researchers can test every gene simultaneously and use AI to extract insights from massive datasets.

Direct genetic intervention in human cells

Scientists can now remove human cells, make precise genetic changes in the lab, observe consequences through DNA sequencing, and translate these findings directly into clinical trials.

Step-function change in medical capability

The combination of DNA sequencing, gene editing, and computational tools represents a material leap from past decades, enabling root-cause intervention rather than symptom management.